990 / 1068
Other Prognostic Factors
•
Male gender
EORTC 22861 :
local control p= 0.0028
overall survival p=0.0034
RTOG 98-11 :
disease free survival p = 0.02
overall survival p=0.016
ACT 1 Trial :
Loco-regional failure HR 1.6 ( 1.03-2.49) p=0.036
Anal cancer death HR 1.8 ( 1.03-3.16) p=0.039
Overall survival HR 1.56 ( 1.12 – 2.17) p=0.008